Sept. 30, 2024

Nearly 50 million adults in the United States reported using tobacco products, including cigarettes and e-cigarettes, in 2022. Half of them tried to quit smoking, according to the CDC, with many relapsing. This highlights the importance of developing treatments and programs that help people quit smoking for good.

Brett Froeliger, a researcher with the University of Missouri’s School of Medicine and the College of Arts and Science, recently received nearly $3.4 million from the National Institutes of Health to continue his work developing treatments for substance use disorders such as nicotine addiction.

This story originally appeared on Show Me Mizzou. 
Want more stories like this? Subscribe to the Show Me Mizzou Newsletter.